INBX EPS Estimates
Inhibrx Biosciences, Inc.
$90.50
+$5.24(+6.15%)
38
Overall
40
Value
30
Tech
44
Quality
Market Cap
$1.25B
Volume
226.36K
52W Range
$46.01 - $155.29
Target Price
$266.67
INBX EPS estimates: the consensus estimate for Inhibrx Biosciences, Inc.'s current fiscal year is -$9.91 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
INBX EPS Estimates
- EPS estimate, current quarter
- $-2.50
- EPS estimate, next quarter
- $-2.91
- EPS estimate, current year
- $-9.91
- EPS estimate, next year
- $-9.34
- EPS growth, 3-year
- -35.67%
| Fiscal year | EPS |
|---|---|
| 2025 | $-9.04 |
| 2024 | $114.01 |
| 2023 | $-20.48 |
| 2022 | $-3.62 |
| 2021 | $-2.15 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INBX | $90.50 | +6.1% | 226.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inhibrx Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW